Goldhardt O - Search Results

1

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia.

Meeter LHH, Steketee RME, Salkovic D, Vos ME, Grossman M, McMillan CT, Irwin DJ, Boxer AL, Rojas JC, Olney NT, Karydas A, Miller BL, Pijnenburg YAL, Barkhof F, Sánchez-Valle R, Lladó A, Borrego-Ecija S, Diehl-Schmid J, Grimmer T, Goldhardt O, Santillo AF, Hansson O, Vestberg S, Borroni B, Padovani A, Galimberti D, Scarpini E, Rohrer JD, Woollacott IOC, Synofzik M, Wilke C, de Mendonca A, Vandenberghe R, Benussi L, Ghidoni R, Binetti G, Niessen WJ, Papma JM, Seelaar H, Jiskoot LC, de Jong FJ, Donker Kaat L, Del Campo M, Teunissen CE, Bron EE, Van den Berg E, Van Swieten JC. Meeter LHH, et al. Among authors: goldhardt o. J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):997-1004. doi: 10.1136/jnnp-2018-319784. Epub 2019 May 23. J Neurol Neurosurg Psychiatry. 2019. PMID: 31123142 Free PMC article.

2

Trends of patient referral to a memory clinic and towards earlier diagnosis from 1985-2009.

Grimmer T, Beringer S, Kehl V, Alexopoulos P, Busche A, Förstl H, Goldhardt O, Natale B, Ortner M, Peters H, Riedl L, Roßmeier C, Valentin W, Diehl-Schmid J, Kurz A. Grimmer T, et al. Among authors: goldhardt o. Int Psychogeriatr. 2015 Dec;27(12):1939-44. doi: 10.1017/S104161021500157X. Epub 2015 Oct 2. Int Psychogeriatr. 2015. PMID: 26424328

3

Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.

Grimmer T, Wutz C, Alexopoulos P, Drzezga A, Förster S, Förstl H, Goldhardt O, Ortner M, Sorg C, Kurz A. Grimmer T, et al. Among authors: goldhardt o. J Nucl Med. 2016 Feb;57(2):204-7. doi: 10.2967/jnumed.115.163717. Epub 2015 Nov 19. J Nucl Med. 2016. PMID: 26585056 Free article.

4

Begcevic I, Brinc D, Brown M, Martinez-Morillo E, Goldhardt O, Grimmer T, Magdolen V, Batruch I, Diamandis EP. Begcevic I, et al. Among authors: goldhardt o. J Proteomics. 2018 Jun 30;182:12-20. doi: 10.1016/j.jprot.2018.04.027. Epub 2018 Apr 22. J Proteomics. 2018. PMID: 29684683

5

Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain Volumetry.

Hedderich DM, Spiro JE, Goldhardt O, Kaesmacher J, Wiestler B, Yakushev I, Zimmer C, Boeckh-Behrens T, Grimmer T. Hedderich DM, et al. Among authors: goldhardt o. J Alzheimers Dis. 2018;65(4):1459-1467. doi: 10.3233/JAD-180532. J Alzheimers Dis. 2018. PMID: 30175976

6

FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations.

Diehl-Schmid J, Licata A, Goldhardt O, Förstl H, Yakushew I, Otto M, Anderl-Straub S, Beer A, Ludolph AC, Landwehrmeyer GB, Levin J, Danek A, Fliessbach K, Spottke A, Fassbender K, Lyros E, Prudlo J, Krause BJ, Volk A, Edbauer D, Schroeter ML, Drzezga A, Kornhuber J, Lauer M; FTLDc Study Group; Grimmer T. Diehl-Schmid J, et al. Among authors: goldhardt o. Transl Psychiatry. 2019 Jan 31;9(1):54. doi: 10.1038/s41398-019-0381-1. Transl Psychiatry. 2019. PMID: 30705258 Free PMC article.

7

Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's Disease.

Grimmer T, Goldhardt O, Yakushev I, Ortner M, Sorg C, Diehl-Schmid J, Förstl H, Kurz A, Perneczky R, Miners S. Grimmer T, et al. Among authors: goldhardt o. Neurodegener Dis. 2019;19(1):43-50. doi: 10.1159/000500811. Epub 2019 Jul 2. Neurodegener Dis. 2019. PMID: 31266021

8

Goldhardt O, Warnhoff I, Yakushev I, Begcevic I, Förstl H, Magdolen V, Soosaipillai A, Diamandis E, Alexopoulos P, Grimmer T. Goldhardt O, et al. Transl Neurodegener. 2019 Aug 27;8:25. doi: 10.1186/s40035-019-0168-6. eCollection 2019. Transl Neurodegener. 2019. PMID: 31467673 Free PMC article.

9

Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease.

Ortner M, Drost R, Hedderich D, Goldhardt O, Müller-Sarnowski F, Diehl-Schmid J, Förstl H, Yakushev I, Grimmer T. Ortner M, et al. Among authors: goldhardt o. BMC Neurol. 2019 Oct 31;19(1):264. doi: 10.1186/s12883-019-1498-9. BMC Neurol. 2019. PMID: 31672138 Free PMC article.

10

Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease.

Ortner M, Drost R, Hedderich D, Goldhardt O, Müller-Sarnowski F, Diehl-Schmid J, Förstl H, Yakushev I, Grimmer T. Ortner M, et al. Among authors: goldhardt o. BMC Neurol. 2020 Mar 5;20(1):80. doi: 10.1186/s12883-020-01649-9. BMC Neurol. 2020. PMID: 32138693 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters